Quick Answer
COGNITION THERAPEUTICS INC reported Research And Development Expense of $37.19 million for the year ending 2025.
- COGNITION THERAPEUTICS INC showed a decrease of -10.8% in Research And Development Expense from 2024 to 2025.
- This data is from COGNITION THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), COGNITION THERAPEUTICS INC's Research And Development Expense has grown by 188.6%.
- Historical annual values: Fiscal year 2025: $37.19 million | Fiscal year 2024: $41.68 million | Fiscal year 2023: $37.20 million | Fiscal year 2022: $30.32 million | Fiscal year 2021: $18.57 million | Fiscal year 2020: $12.89 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: